+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America Cell Expansion Market to 2027 - Regional Analysis and Forecasts by Product; Cell Type; Application; End User, and Country

  • PDF Icon

    Report

  • 165 Pages
  • March 2020
  • Region: North America
  • The Insight Partners
  • ID: 5018049
UP TO OFF until Jan 15th 2023
The cell expansion market in North America is anticipated to reach USD 14,697.41 million by 2027 from USD 4,522.07 4 million in 2019; it is projected to grow at a CAGR of 15.9% during 2020-2027. The growth of the market is attributed to the increasing prevalence of cancer, rising number of new product launches, and increasing inclination of patients toward regenerative and personalized medicines. Also, growing R&D expenditure on cancer research is likely to have a positive impact on the growth of the market in the coming years. In addition, technological advancements in the pharmaceuticals industry and extensive developments in drug discovery are likely to stimulate the growth of cell expansion market in North America during the forecast period.

Cell expansion is the large-scale artificial production of daughter cells from a single cell, and the process is carried out to support the medical research. It plays a critical role in exploring a wider range of benefits and applications of fully differentiated stem cell cultures for their use in therapeutics, drug screening, or advanced research.

R&D is a significant part of a majority of pharmaceutical and biotech companies; they focus on R&D to come up with new molecules with the most significant medical and commercial potential for various therapeutic applications. The companies invest big amounts in these activities to deliver innovative, high-quality products to the market. Moreover, as per the report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expense of biopharmaceutical companies surged from US$ 49.6 billion in 2012 to US$ 58.8 billion in 2015. Several government organizations are working on enhancing the detection methods and treatment procedures of cancer in the region. The National Cancer Institute (NCI) spends on various categories of the treatment, including specific cancer sites, cancer types, and cancer-related diseases, as well as types of NCI research mechanisms. The NCI allocated the funds of ~US$ 208.4 million for cell expansion research in 2017 from their total budget of US$ 5,636.4 million in that year for cancer research studies. Therefore, the growing R&D expenditure on cancer research by these companies is expected to provide them with opportunities for business expansion.

The North American cell expansion market has been segmented on the basis of cell type into human cells and animal cells. The human cells segment held a larger share of the market in 2018, and it is also projected to register a higher CAGR in it during the forecast period. Rise in research activities for the treatment of cancer is expected to offer considerable growth opportunities for the human cell expansion market players.

A few of the important secondary sources referred to for preparing this report on the cell expansion market are World Health Organization (WHO), Food and Drug Administration (FDA), Canadian Cancer Society, Centers for Disease Control and Prevention (CDC), and American Cancer Society.

Reasons to Buy:
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America cell expansion market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the North America cell expansion market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 North America Cell Expansion Market - By Product
1.3.2 North America Cell Expansion Market - By Cell Type
1.3.3 North America Cell Expansion Market - By Application
1.3.4 North America Cell Expansion Market - By End User
1.3.5 North America Cell Expansion Market - By Country
2. North America Cell Expansion Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Cell Expansion Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Expansion Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Cell Expansion Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Patient shift towards regenerative medicines
5.1.2 Increasing number of patients suffering with cancer
5.2 Key Restraints
5.2.1 Risk of contamination associated with the cell expansion process
5.3 Key Market Opportunities
5.3.1 Growing R&D Expenditure for Cancer Research
5.4 Future Trend
5.4.1 Extensive development in drug discovery
5.5 Impact Analysis
6. Cell Expansion Market - North America Analysis
6.1 North America Cell Expansion Market Revenue Forecasts and Analysis
6.2 Positioning Of Key Players
7. North America Cell Expansion Market Analysis And Forecasts To 2027 - Product
7.1 Overview
7.2 North America Cell Expansion Market, By Product 2018 & 2027 (%)
7.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.2.1.1 North America Consumables Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.2.1.1.1 North America Disposables Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.2.1.2 North America Instruments Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 Consumables
7.3.1 Overview
7.3.2 North America Consumables Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Reagents, Media & Serum
7.3.3.1 Overview
7.3.3.2 North America Reagents, Media & Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4 Disposables
7.3.4.1 Overview
7.3.4.2 North America Disposables Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4.3 Culture Tissue Flasks
7.3.4.3.1 Overview
7.3.4.3.2 North America Culture Tissue Flasks Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4.4 Bioreactor Accessories
7.3.4.4.1 Overview
7.3.4.4.2 North America Bioreactor Accessories Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4.5 Other Disposables
7.3.4.5.1 Overview
7.3.4.5.2 North America Other Disposables Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Instruments
7.4.1 Overview
7.4.2 North America Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 Cell Expansion Supporting Equipment
7.4.3.1 Overview
7.4.3.2 North America Cell Expansion Supporting Equipment Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Bioreactors
7.4.4.1 Overview
7.4.4.2 North America Bioreactors Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Automated Cell Expansion Systems
7.4.5.1 North America Automated Cell Expansion Systems Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Cell Expansion Market Analysis And Forecasts To 2027 - Cell Type
8.1 Overview
8.2 North America Cell Expansion Market, By Cell Type 2018 & 2027 (%)
8.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By Cell Type (US$ Mn)
8.3 Human Cells
8.3.1 Overview
8.3.2 North America Human Cells Market Revenue and Forecast to 2027 (US$ Mn)
8.3.3 Adult Stem Cells
8.3.3.1 Overview
8.3.3.2 North America Adult Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)
8.3.4 Induced Pluripotent Stem Cells
8.3.4.1 Overview
8.3.4.2 North America Induced Pluripotent Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)
8.3.5 Embryonic Stem Cells
8.3.5.1 Overview
8.3.5.2 North America Embryonic Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)
8.3.6 Differentiated Cells
8.3.6.1 Overview
8.3.6.2 North America Differentiated Cells Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Animal Cells
8.4.1 Overview
8.4.2 North America Animal Cells Market Revenue and Forecast to 2027 (US$ Mn)
9. North America Cell Expansion Market Analysis- By Application
9.1 Overview
9.2 North America Cell Expansion Market, By Application 2018 & 2027 (%)
9.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 Regenerative Medicine and Stem Cell Research
9.3.1 Overview
9.3.2 North America Regenerative Medicine and Stem Cell Research Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Cancer and Cell-based Research
9.4.1 Overview
9.4.2 North America Cancer and Cell-based Research Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Other Applications
9.5.1 Overview
9.5.2 North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
10. North America Cell Expansion Market Analysis- By End User
10.1 Overview
10.2 North America Cell Expansion Market, By End User 2018 & 2027 (%)
10.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3 Biopharmaceutical And Biotechnology Companies
10.3.1 Overview
10.3.2 North America Biopharmaceutical And Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Research Institutes
10.4.1 Overview
10.4.2 North America Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Cell Banks
10.5.1 Overview
10.5.2 North America Cell Banks Market Revenue and Forecasts to 2027 (US$ Mn)
10.6 Other End Users
10.6.1 Overview
10.6.2 North America Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
11. Cell Expansion Market Revenue And Forecasts To 2027 - Geographical Analysis
11.1 North America Cell Expansion Market, Revenue and Forecast to 2027
11.1.1 North America Cell Expansion Market, Revenue and Forecast to 2027 (US$ Mn)
11.1.2 North America Cell Expansion Market, Revenue and Forecast to 2027, By Product (US$ Mn)
11.1.2.1 North America Consumables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.2.1.1 North America Disposables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.2.2 North America Instruments Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.3 North America Cell Expansion Market, Revenue and Forecast to 2027, By Cell Type (US$ Mn)
11.1.3.1 North America Human Cell Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.4 North America Cell Expansion Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11.1.5 North America Cell Expansion Market, Revenue and Forecast to 2027, By End User (US$ Mn)
11.1.6 North America Cell Expansion Market, Revenue and Forecast to 2027, By Country (%)
11.1.7 US
11.1.7.1 US Cell Expansion Market, Revenue and Forecast to 2027 (US$ Mn)
11.1.7.2 US Cell Expansion Market, Revenue and Forecast to 2027, By Product (US$ Mn)
11.1.7.2.1 US Consumables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.7.2.1.1 US Disposables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.7.2.2 US Instruments Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.8 US Cell Expansion Market, Revenue and Forecast to 2027, By Cell Type (US$ Mn)
11.1.8.1 US Human Cell Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.9 US Cell Expansion Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11.1.10 US Cell Expansion Market, Revenue and Forecast to 2027, By End User (US$ Mn)
11.1.11 Canada
11.1.11.1 Canada Cell Expansion Market, Revenue and Forecast to 2027 (US$ Mn)
11.1.11.2 Canada Cell Expansion Market, Revenue and Forecast to 2027, By Product (US$ Mn)
11.1.11.2.1 Canada Consumables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.11.2.1.1 Canada Disposables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.11.2.2 Canada Instruments Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.12 Canada Cell Expansion Market, Revenue and Forecast to 2027, By Cell Type (US$ Mn)
11.1.12.1 Canada Human Cell Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.13 Canada Cell Expansion Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11.1.14 Canada Cell Expansion Market, Revenue and Forecast to 2027, By End User (US$ Mn)
11.1.15 Mexico
11.1.15.1 Mexico Cell Expansion Market, Revenue and Forecast to 2027 (US$ Mn)
11.1.15.2 Mexico Cell Expansion Market, Revenue and Forecast to 2027, By Product (US$ Mn)
11.1.15.2.1 Mexico Consumables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.15.2.1.1 Mexico Disposables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.15.2.2 Mexico Instruments Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.16 Mexico Cell Expansion Market, Revenue and Forecast to 2027, By Cell Type (US$ Mn)
11.1.16.1 Mexico Human Cell Market, Revenue and Forecast to 2027, By Type (US$ Mn)
11.1.17 Mexico Cell Expansion Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11.1.18 Mexico Cell Expansion Market, Revenue and Forecast to 2027, By End User (US$ Mn)
12. North America Cell Expansion Market- Industry Landscape
12.1 Overview
12.2 Growth Strategies In The Cell Expansion Market, 2017-2019
12.3 Organic Growth Strategies
12.3.1 Overview
12.3.1.1 Recent Organic Developments By Players In The Cell Expansion Market
12.4 Inorganic Growth Strategies
12.4.1 Overview
12.4.2 Recent Developments By Players In The Cell Expansion Market
13. Global Cell Expansion Market-Key Company Profiles
13.1 BD
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Information
13.3.4 Product /Services Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product portfolio
13.4.5 SWOT ANALYSIS
13.4.6 Key Developments
13.5 General Electric Company
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Corning Incorporated
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Miltenyi Biotec
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Information
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lonza
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Information
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 STEMCELL Technologies, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Information
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • BD
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Terumo Corporation
  • General Electric Company
  • Corning Incorporated
  • Miltenyi Biotec
  • Danaher
  • Lonza
  • Stemcell Technologies, Inc.